A detailed history of Israel Englander (Millennium Management LLC) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Millennium Management LLC holds 1,568,553 shares of DVAX stock, worth $17.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,568,553
Holding current value
$17.8 Million
% of portfolio
0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.73 - $12.58 $16.8 Million - $19.7 Million
1,568,553 New
1,568,553 $17.6 Million
Q4 2023

Feb 14, 2024

BUY
$13.09 - $14.98 $3.62 Million - $4.14 Million
276,362 Added 72.33%
658,433 $9.2 Million
Q2 2023

Aug 14, 2023

SELL
$9.85 - $13.17 $1.18 Million - $1.58 Million
-120,299 Reduced 23.95%
382,071 $4.94 Million
Q1 2023

May 15, 2023

BUY
$9.44 - $11.88 $3.7 Million - $4.66 Million
392,066 Added 355.44%
502,370 $4.93 Million
Q4 2022

Feb 14, 2023

SELL
$10.27 - $13.29 $8.26 Million - $10.7 Million
-803,886 Reduced 87.93%
110,304 $1.17 Million
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $7.02 Million - $12.3 Million
707,112 Added 341.47%
914,190 $9.54 Million
Q2 2022

Aug 15, 2022

SELL
$7.45 - $12.83 $11.1 Million - $19.2 Million
-1,494,031 Reduced 87.83%
207,078 $2.61 Million
Q1 2022

May 16, 2022

SELL
$9.75 - $14.44 $676,650 - $1 Million
-69,400 Reduced 3.92%
1,701,109 $18.4 Million
Q4 2021

Feb 14, 2022

BUY
$13.17 - $20.94 $18.6 Million - $29.6 Million
1,412,111 Added 394.01%
1,770,509 $24.9 Million
Q3 2021

Nov 15, 2021

SELL
$9.16 - $19.83 $68,480 - $148,249
-7,476 Reduced 2.04%
358,398 $6.89 Million
Q2 2021

Aug 16, 2021

SELL
$7.25 - $10.99 $3.37 Million - $5.11 Million
-465,306 Reduced 55.98%
365,874 $3.6 Million
Q1 2021

May 17, 2021

BUY
$4.57 - $11.18 $3.32 Million - $8.13 Million
727,016 Added 697.95%
831,180 $8.17 Million
Q4 2020

Feb 16, 2021

SELL
$3.73 - $5.6 $3.78 Million - $5.67 Million
-1,013,187 Reduced 90.68%
104,164 $464,000
Q3 2020

Nov 16, 2020

BUY
$4.32 - $11.7 $4.83 Million - $13.1 Million
1,117,351 New
1,117,351 $4.83 Million
Q2 2020

Aug 14, 2020

SELL
$2.94 - $9.1 $592,142 - $1.83 Million
-201,409 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$2.27 - $6.2 $334,098 - $912,516
-147,180 Reduced 42.22%
201,409 $711,000
Q4 2019

Feb 14, 2020

SELL
$3.46 - $6.93 $1.68 Million - $3.37 Million
-485,584 Reduced 58.21%
348,589 $1.99 Million
Q3 2019

Nov 14, 2019

SELL
$2.69 - $4.85 $3.74 Million - $6.74 Million
-1,389,128 Reduced 62.48%
834,173 $2.98 Million
Q2 2019

Aug 14, 2019

SELL
$3.65 - $7.89 $267,019 - $577,200
-73,156 Reduced 3.19%
2,223,301 $8.87 Million
Q1 2019

May 14, 2019

BUY
$7.08 - $12.09 $11.9 Million - $20.3 Million
1,681,527 Added 273.45%
2,296,457 $16.8 Million
Q4 2018

Feb 14, 2019

BUY
$8.14 - $13.28 $4.19 Million - $6.84 Million
514,736 Added 513.74%
614,930 $5.63 Million
Q3 2018

Nov 14, 2018

SELL
$11.85 - $16.0 $352,039 - $475,328
-29,708 Reduced 22.87%
100,194 $1.24 Million
Q2 2018

Aug 14, 2018

BUY
$15.15 - $20.75 $1.28 Million - $1.75 Million
84,254 Added 184.57%
129,902 $1.98 Million
Q1 2018

May 15, 2018

SELL
$14.65 - $19.9 $811,448 - $1.1 Million
-55,389 Reduced 54.82%
45,648 $906,000
Q4 2017

Feb 14, 2018

BUY
$17.3 - $24.08 $1.75 Million - $2.43 Million
101,037
101,037 $1.89 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.44B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.